当サイトでは、利用測定やトラフィック分析を目的として、クッキー(Cookie)を利用しています。
「同意する」ボタンや本サイトをクリックすることで、クッキーの利用に同意いただいたことになります。
詳しくはプライバシーポリシー
をご覧ください。
当サイトでは、利用測定やトラフィック分析を目的として、クッキー(Cookie)を利用しています。
「同意する」ボタンや本サイトをクリックすることで、クッキーの利用に同意いただいたことになります。
詳しくはプライバシーポリシーをご覧ください。
| 診療科 | 血液腫瘍科 |
|---|---|
| 専門治療 | Medical Oncology |
Dr Tan is a senior consultant medical oncologist at the National University Cancer Institute, Singapore and an Associate Professor in the Department of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore and Principal Investigator at the Cancer Science Institute, National University of Singapore. His primary clinical and research interests are in gynaecological cancers, precision oncology, and early phase trials (link to publications: https://discovery.nus.edu.sg/4508-shao-peng-david-tan/publications). Dr Tan is currently the Group Director of Partnerships and Innovation at National University Health Systems (NUHS) and Director of the Research Transformation Office at NUHS. He was the founding President of the Gynecologic Cancer Group Singapore (GCGS), and inaugural President of the Asia-Pacific Gynaecologic Oncology Trials (APGOT) Group. He currently chairs the APGOT Protocol Review Committee. He is also the past-chair of the Cervical Cancer Research Network (CCRN) of the of the Gynecologic Cancer InterGroup (GCIG) and is a member of the executive board of directors of the GCIG.
Gynaecological cancers, precision oncology, and early phase trials
Medical Oncology
| 2026-Present | Group Director Partnerships and Innovation (NUHS Research and Innovation Office), National University Health System (NUHS) |
| 2024-Present | Director Research Transformation Office in Deputy Chief Executive Office for Research and Education, NUHS |
